SPECT Biomarker Ctte: Difference between revisions

From QIBA Wiki
Jump to navigation Jump to search
VisualWikitext
Sweinmann (talk | contribs)
1,270 edits
Created page with "==Project Snapshot== The SPECT Biomarker Committee seeks to develop a quantitative imaging profile for SPECT imaging. Under consideration: *quantifying a small structure (l..."
 
mNo edit summary
 
(78 intermediate revisions by 5 users not shown)
Line 1: Line 1:
{{TOCright}}
:Co-chairs: Yuni Dewaraja, PhD; P. David Mozley, MD; John Seibyl, MD
* [http://tinyurl.com/QIBA-SPECT-Roster Roster]
==Project Snapshot==
==Project Snapshot==
The SPECT Biomarker Committee seeks to develop a quantitative imaging profile for SPECT imaging.   
The SPECT Biomarker Committee seeks to develop a quantitative imaging profile for SPECT imaging.   


Under consideration:
'''Under consideration:'''
*quantifying a small structure (like the basal ganglion in the DaTscan, thyroid)   
*quantifying a small structure (like the basal ganglion in the DaTscan, thyroid)   
*quantifying organs, like the liver, for dosimetry as potential use cases
*quantifying organs, like the liver, for dosimetry as potential use cases


==Meetings/Call Summaries==
'''Established Task Forces''' currently working toward a first Profile titled: <font color=blue>''Quantifying Dopamine Transporters with 123-Iodine labeled Ioflupane in Neurodegenerative Disease''</font> 
*[[SPECT Call Summaries]]
 
* Image Acquisition and Image Processing for DaTscan – ''Dr. Dewaraja''
* Quantitative / Image Analysis – ''Drs. Miyaoka and Seibyl''
* Phantoms / DRO Group – ''Drs. Dickson and Zimmerman''
* Clinical / Literature Review – ''Dr. Seibyl''
 
==Recent Meetings/Call Summaries==
 
*[[Media:02 16 2018 QIBA SPECT Call Summary-FINAL.pdf|February 16, 2018]]
*[[Media:01 19 2018 QIBA SPECT Call Summary-FINAL.pdf|January 19, 2018]]
*[[Media:10 20 2017 QIBA SPECT Call Summary-FINAL.pdf|October 20, 2017]]
 
'''''[[SPECT BC Call Summaries Archive]]'''''
 
==Literature Review (Profile 1.0)==
*[[Media:QIBA SPECT Literature Review-22 March 2016.pdf |  QIBA Literature Review Slides for Profile 1.0 - Dr. Seibyl]] ''March 22, 2016''


   
*[[Media:QIBA SPECT Literature Review-22 March 2016.docx | QIBA Literature Review for Profile 1.0 (Word document) - Dr. Seibyl]] ''March 22, 2016''
==Working Documents==


==Profile Development==
==Statistical Reference Documents==


==Workflow Documents==
*[[Media:001.QIBA SPECT Ioflupane Profile.v1.0 post-public comments.2017 08 29.docx | QIBA Profile: Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.1), August 28, 2017]]


*[[Media:001.QIBA SPECT Ioflupane Profile.v1.0 post-public comments.clean copy.2017 06 26.docx | QIBA Profile: Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.1), June 26, 2017]]
*[[Media:001.QIBA SPECT Profile.v0.1 2016.10.28.docx | QIBA Profile: Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.0), October 28, 2016]]
*[[Media:002.QIBA SPECT Profile Checklist Extract.2016 10 31.docx|QIBA Profile Checklist: SPECT Profile Conformance]]
*[[Media:001.QIBA_SPECT_Profile.v0.1_2016.05.10.docx | QIBA DRAFT Profile with tracked changes - {Dr. Miyaoka}]] ''May 10, 2016''
*[[Media:001.QIBA_SPECT_Profile.v0.1_2016.05.1.docx | QIBA DRAFT Profile with tracked changes - {Dr. Dewaraja}]] ''May 1, 2016''
*[[Media:001.QIBA_SPECT_Profile.v0.1_2016.04.15b.docx | QIBA DRAFT Profile with tracked changes - {Dr. Mozley}]] ''April 15, 2016''
*[[Media:001.QIBA_SPECT_Profile.v0.1_2016.04.05.docx | QIBA DRAFT Profile with tracked changes for recent additions and homework - {Dr. E. Frey}]] ''April 5, 2016''
*[[Profile drafts|Archived past versions of the Profile]]


==Reference Materials==
==Reference Materials==


03.20.2015 Link to papers of the group in Umeå that are collaborating with Dr. Ljungberg:
*[[Media:Literature Review 23Aug2016.pdf | QIBA SPECT TF presentation slides - Dr. Seibyl]] ''August 23, 2016''
 
*[[Media:QIBA big BC agenda.2016 07 15-yuniupdated2.pdf | QIBA SPECT BC presentation slides - Dr. Mozley]] ''July 15, 2016''
 
*[[Media:qiba agenda 12 july_rsm.pdf |  QIBA SPECT BC presentation slides - Dr. Miyaoka]] ''July 12, 2016''
 
*[[Media:qiba agenda 10 may_rsm_v2.pdf |  QIBA SPECT BC presentation slides - Dr. Miyaoka]] ''May l0, 2016''
 
*[[Media:Image Acquisition and Reconstruction.pdf |  QIBA SPECT BC presentation slides - Dr. Dewaraja]] ''May 5, 2016''
 
*[[Media:DATscan_DRO.pdf |  QIBA SPECT BC presentation slides - Dr. Miyaoka]] ''April 22, 2016''
 
*[[Media:QIBA SPECT Quantitative and Image Analysis-8 March 2016.pdf |  QIBA SPECT BC presentation slides - Dr. Seibyl]] ''March 8, 2016''
 
*[[Media:QIBA SPECT DAcq and Proc-Feb 2016.pdf |  QIBA SPECT BC presentation slides - Dr. Frey]] ''February 2, 2016''
 
*[[Media:QSPECT_EJNM_QIBA_02Feb2016.pdf |  QIBA SPECT BC presentation slides - Dr. Buchert]] ''February 2, 2016''
 
*[[Media:QIBA SPECT BC- 22 jan2016 v1.pdf |  QIBA SPECT BC presentation slides - Dr. Seibyl]] ''January 22, 2016''
 
*[[Media:Quant_DataAnalysis_12Jan2016_rsm.pdf | Quantification and Image Analysis Task Force presentation slides - Dr. Miyaoka]] ''January 12, 2016''
 
*[[Media:QIBA12jan2016.pdf | Quantification and Image Analysis Task Force presentation slides - Dr. Seibyl]] ''January 12, 2016''
 
*[[Media:I-123 DAT SCAN - Acquisition and Reconstruction Task Force.pdf | I-123 DAT SCAN - Acquisition and Reconstruction Task Force presentation slides - Dr. Dewaraja]] ''January 5, 2016''
 
*[[Media:Acquisition Process.pdf | Acquisition Processes for SPECT - Drs.  Dewaraja, Frey, and Iida (notes)]] ''December 8, 2015''
 
*[[Media:System Variance Model for SPECT Ioflupane.pdf | System Variance Model for SPECT Ioflupane - Drs.  Smith and Zeintl (Siemens)]] ''November 20, 2015''
 
*[[Media:QIBA Claim Statement Types.pdf | QIBA Claim Statement Types - Dr. Obuchowski]] ''November 20, 2015''
 


The PI for this is Anne Larsson, PhD: http://www.ncbi.nlm.nih.gov/pubmed/?term=dat+scan+Larsson+A
*03.20.2015 Link to papers of the group in Umeå that are collaborating with Dr. Ljungberg:
*The PI for this is Anne Larsson, PhD: http://www.ncbi.nlm.nih.gov/pubmed/?term=dat+scan+Larsson+A

Latest revision as of 18:46, 21 December 2023

Co-chairs: Yuni Dewaraja, PhD; P. David Mozley, MD; John Seibyl, MD

Project Snapshot

The SPECT Biomarker Committee seeks to develop a quantitative imaging profile for SPECT imaging.

Under consideration:

  • quantifying a small structure (like the basal ganglion in the DaTscan, thyroid)
  • quantifying organs, like the liver, for dosimetry as potential use cases

Established Task Forces currently working toward a first Profile titled: Quantifying Dopamine Transporters with 123-Iodine labeled Ioflupane in Neurodegenerative Disease

  • Image Acquisition and Image Processing for DaTscan – Dr. Dewaraja
  • Quantitative / Image Analysis – Drs. Miyaoka and Seibyl
  • Phantoms / DRO Group – Drs. Dickson and Zimmerman
  • Clinical / Literature Review – Dr. Seibyl

Recent Meetings/Call Summaries

SPECT BC Call Summaries Archive

Literature Review (Profile 1.0)

Profile Development

Reference Materials


Retrieved from "https://qibawiki.rsna.org/index.php?title=SPECT_Biomarker_Ctte&oldid=19488"